Patients on the higher dose of 7.2 milligrams for about 18 months lost 21% of their body weight on average, a study found.

Novo Nordisk's plan to gain ground in the GLP-1 space is slowly taking shape.

Only one spot — Novo Nordisk’s for Wegovy — touts a branded pharmaceutical drug. Two of the five encourage screenings for ...

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is ...

Novo Nordisk beat analyst expectations for the fourth quarter, but the result was overshadowed by softened expectations for this year.

Novo Nordisk (NVO) stock will produce Wegovy pills in Ireland after attracting 240,000 users in five weeks as CEO battles Eli ...

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, ...

Semaglutide is the active ingredient in Ozempic and Wegovy. It’s a synthetic form of GLP-1, a hormone that regulates our ...

Growth, value, or both?

Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill ...

Novo’s 90-second ad features a coterie of celebs promoting the oral version of its blockbuster weight loss drug Wegovy.

Novo Nordisk on Tuesday said it expects sales and profits to decline this year, as the maker of Wegovy faces growing ...